Other equities research analysts also recently issued research reports about the company. JPMorgan Chase & Co. upped their target price on PTC from $200.00 to $210.00 and gave the stock an ...

PTC – Free Report) by 83.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 452 shares of the ...

BOSTON - PTC (NASDAQ: PTC), a global software company with a market capitalization of $18.79 billion and impressive gross profit margins of 80.7%, announced today the acquisition of IncQuery Group ...

BOSTON - PTC (NASDAQ: PTC), a global software company with a market capitalization of $18.79 billion and impressive gross profit margins of 80.7%, announced today the acquisition of IncQuery Group, a ...

Nicole Kidman, Matthew Macfadyen and Gael García Bernal star in 'Holland,' a new thriller on Prime Video Benjamin VanHoose is a Staff Editor on the Movies team at PEOPLE. He has written about ...

Before Nicole Kidman rocked her loose blonde waves, she was the poster girl for '90s tendrils and often embraced her naturally curly locks with voluminous strawberry blonde ringlets. A far cry ...

AUSTIN – Another reason has sprouted to give Nicole Kidman her fashion flowers – we’re thinking tulips for the “Holland” star. Kidman, 57, stunned at Sunday’s premiere during Austin ...

Nicole Kidman is no stranger to style transformations. The Babygirl actress is never afraid to switch up her style, especially when it comes to dressing up for press tours for her different ...

Former Rep. Katie Porter (D-Calif.) announced her bid for California governor Tuesday, joining a growing field of Democratic contenders in the race to succeed Gov. Gavin Newsom (D). In an ...

WARREN, N.J. - PTC Therapeutics, Inc. (NASDAQ: PTCT), a biopharmaceutical company with a market capitalization of $4.34 billion, has encountered a regulatory hurdle as the European Commission (EC ...

WARREN, N.J. - PTC Therapeutics, Inc. (NASDAQ: PTCT), a biopharmaceutical company with a market capitalization of $4.49 billion, has presented new findings from its Phase 3 APHENITY trial and ...